Drug Discovery Biologics CRO

PUBLISHER: The Insight Partners | PRODUCT CODE: 1761162

PUBLISHER: The Insight Partners | PRODUCT CODE: 1761162

Biopharmaceutical Contract Manufacturing Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Source, Application, Therapeutic Area, and Geography

PUBLISHED: June 17, 2025

PAGES: 243 Pages

DELIVERY TIME: 1-5 business days

ADD TO COMPARE

SELECT AN OPTION

The biopharmaceutical contract manufacturing market size is expected to grow from US$ 40.99 billion in 2024 to US$ 101.05 billion by 2031; it is projected to register a CAGR of 13.8% during 2025-2031. Rising demand for biologics and increasing demand for cost efficiency and flexibility are noteworthy factors contributing to the expansion of the biopharmaceutical contract manufacturing market size. However, the tightened budget and economic uncertainty hinder the biopharmaceutical contract manufacturing market growth.

Monoclonal antibodies, gene therapies, and cell-based treatments have created the need for more innovative, streamlined manufacturing processes. As a result, contract manufacturing organizations (CMOs) are increasingly adopting advanced technologies such as continuous manufacturing, automation, artificial intelligence (AI), and process analytical technologies (PAT) to enhance production capabilities and meet the growing demand for biopharmaceuticals. Continuous manufacturing is rapidly gaining traction in the biopharmaceutical industry as it allows the uninterrupted production of biologics, providing greater consistency, speed, and efficiency. This process reduces downtime between production runs and minimizes the need for intermediate storage, significantly reducing production costs. According to a Baker McKenzie report, continuous manufacturing can reduce the cost of biologic production by 30%. Novartis and Pfizer are among the major companies implementing continuous manufacturing for large-scale biologic production, demonstrating its effectiveness in improving operational efficiency and reducing costs.

Artificial intelligence (AI) can also be used for process optimization, predictive maintenance, and quality control. AI-based tools can analyze vast amounts of production data in real-time, identifying potential issues before they arise and ensuring optimal conditions throughout the production process. This technology helps CMOs minimize downtime and improve yield rates. Companies such as Cognizant are already using AI to predict potential failures in manufacturing processes and improve decision-making. Furthermore, process analytical technologies (PAT) enable real-time monitoring and control of critical process parameters, ensuring consistent quality across large batches of biologics. By integrating PAT, manufacturers can detect variations early in the production process and adjust in real-time to prevent defects or inconsistencies. This results in higher-quality products and more efficient use of resources, reducing both time and cost. Therefore, the increasing adoption of advanced manufacturing technologies such as continuous manufacturing, automation, AI, and PAT is expected to contribute to the growth of the biopharmaceutical contract manufacturing market in the coming years.

Therapeutic Area-Based Insights

Based on the therapeutic area, the biopharmaceutical contract manufacturing market is segmented into oncology, autoimmune disorders, respiratory disorders, metabolic disorders, neurology, infectious diseases, and others. The oncology segment held the largest biopharmaceutical contract manufacturing market share in 2024. As cancer remains a leading cause of death globally, it drives the need for advanced cancer treatments. According to the World Health Organization (WHO), 20 million new cancer cases and 9.7 million cancer-related deaths were reported globally in 2022. This demand is primarily driven by the development of biologics and the production of biologics involves complex cell culture systems and stringent quality control measures, making outsourcing to contract manufacturers a viable solution for many pharmaceutical companies. Keytruda generated US$ 29.48 billion in sales in 2024, highlighting the immense market potential of oncology biologics. Additionally, the increasing trend toward personalized oncology treatments, particularly with CAR-T therapies such as Kymriah (tisagenlecleucel) and Yescarta (axicabtagene ciloleucel), has also fueled the need for highly specialized contract manufacturing. These treatments require the production of genetically modified immune cells, which creates the demand for CMOs with expertise in cell and gene therapies, thereby fueling the biopharmaceutical contract manufacturing market growth.

World Health Organization (WHO), Global Autoimmune Institute 2022 report, and International Diabetes Federation are among the primary and secondary sources referred to while preparing the biopharmaceutical contract manufacturing market report.

Product Code: TIPRE00005512

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Biopharmaceutical Contract Manufacturing Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Biopharmaceutical Contract Manufacturing Market - Key Market Dynamics

5.1 Biopharmaceutical Contract Manufacturing Market - Key Market Dynamics
5.2 Market Drivers:
- 5.2.1 Rising Demand for Biologics
- 5.2.2 Increasing Demand for Cost Efficiency and Flexibility
5.3 Market Restraints
- 5.3.1 Tightened Budget and Economic Uncertainty
5.4 Market Opportunities
- 5.4.1 Increasing Demand for Personalized Medicine
5.5 Future Trends
- 5.5.1 Advanced Manufacturing Technologies
5.6 Impact of Drivers and Restraints:

6. Biopharmaceutical Contract Manufacturing Market - Global Market Analysis

6.1 Biopharmaceutical Contract Manufacturing Market Revenue (US$ Million), 2021-2031
6.2 Biopharmaceutical Contract Manufacturing Market Forecast Analysis

7. Biopharmaceutical Contract Manufacturing Market Analysis - by Product Type

7.1 Biologics
- 7.1.1 Overview
- 7.1.2 Biologics: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Biosimilar
- 7.2.1 Overview
- 7.2.2 Biosimilar: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

8. Biopharmaceutical Contract Manufacturing Market Analysis - by Source

8.1 Microbial
- 8.1.1 Overview
- 8.1.2 Microbial: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Mammalian
- 8.2.1 Overview
- 8.2.2 Mammalian: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

9. Biopharmaceutical Contract Manufacturing Market Analysis - by Application

9.1 Commercial
- 9.1.1 Overview
- 9.1.2 Commercial: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Clinical
- 9.2.1 Overview
- 9.2.2 Clinical: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

10. Biopharmaceutical Contract Manufacturing Market Analysis - by Therapeutic Area

10.1 Oncology
- 10.1.1 Overview
- 10.1.2 Oncology: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Autoimmune Disorders
- 10.2.1 Overview
- 10.2.2 Autoimmune Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Respiratory Disorders
- 10.3.1 Overview
- 10.3.2 Respiratory Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Metabolic Disorders
- 10.4.1 Overview
- 10.4.2 Metabolic Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Neurology
- 10.5.1 Overview
- 10.5.2 Neurology: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Infectious Diseases
- 10.6.1 Overview
- 10.6.2 Infectious Diseases: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
10.7 Others
- 10.7.1 Overview
- 10.7.2 Others: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

11. Biopharmaceutical Contract Manufacturing Market - Geographical Analysis

11.1 North America
- 11.1.1 North America Biopharmaceutical Contract Manufacturing Market Overview
- 11.1.2 North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  - 11.1.2.1 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
  - 11.1.2.2 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
  - 11.1.2.3 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
  - 11.1.2.4 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
- 11.1.3 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
  - 11.1.3.1 United States: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.1.3.1.1 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.1.3.1.2 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.1.3.1.3 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.1.3.1.4 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.1.3.2 Canada: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.1.3.2.1 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.1.3.2.2 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.1.3.2.3 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.1.3.2.4 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.1.3.3 Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.1.3.3.1 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.1.3.3.2 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.1.3.3.3 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.1.3.3.4 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
11.2 Europe
- 11.2.1 Europe Biopharmaceutical Contract Manufacturing Market Overview
- 11.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  - 11.2.2.1 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
  - 11.2.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
  - 11.2.2.3 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
  - 11.2.2.4 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
- 11.2.3 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
  - 11.2.3.1 Germany: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.3.1.1 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.2.3.1.2 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.2.3.1.3 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.2.3.1.4 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.2.3.2 United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.3.2.1 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.2.3.2.2 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.2.3.2.3 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.2.3.2.4 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.2.3.3 France: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.3.3.1 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.2.3.3.2 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.2.3.3.3 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.2.3.3.4 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.2.3.4 Italy: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.3.4.1 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.2.3.4.2 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.2.3.4.3 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.2.3.4.4 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.2.3.5 Spain: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.3.5.1 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.2.3.5.2 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.2.3.5.3 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.2.3.5.4 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.2.3.6 Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.2.3.6.1 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.2.3.6.2 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.2.3.6.3 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.2.3.6.4 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
11.3 Asia Pacific
- 11.3.1 Asia Pacific Biopharmaceutical Contract Manufacturing Market Overview
- 11.3.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  - 11.3.2.1 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
  - 11.3.2.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
  - 11.3.2.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
  - 11.3.2.4 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
- 11.3.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
  - 11.3.3.1 China: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.3.1.1 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.3.3.1.2 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.3.3.1.3 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.3.3.1.4 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.3.3.2 Japan: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.3.2.1 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.3.3.2.2 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.3.3.2.3 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.3.3.2.4 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.3.3.3 India: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.3.3.1 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.3.3.3.2 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.3.3.3.3 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.3.3.3.4 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.3.3.4 Australia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.3.4.1 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.3.3.4.2 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.3.3.4.3 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.3.3.4.4 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.3.3.5 South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.3.5.1 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.3.3.5.2 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.3.3.5.3 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.3.3.5.4 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.3.3.6 Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.3.3.6.1 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.3.3.6.2 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.3.3.6.3 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.3.3.6.4 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
11.4 Middle East & Africa
- 11.4.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Overview
- 11.4.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  - 11.4.2.1 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
  - 11.4.2.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
  - 11.4.2.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
  - 11.4.2.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
- 11.4.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
  - 11.4.3.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.3.1.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.4.3.1.2 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.4.3.1.3 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.4.3.1.4 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.4.3.2 South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.3.2.1 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.4.3.2.2 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.4.3.2.3 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.4.3.2.4 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.4.3.3 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.3.3.1 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.4.3.3.2 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.4.3.3.3 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.4.3.3.4 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.4.3.4 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.4.3.4.1 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.4.3.4.2 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.4.3.4.3 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.4.3.4.4 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
11.5 South & Central America
- 11.5.1 South & Central America Biopharmaceutical Contract Manufacturing Market Overview
- 11.5.2 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  - 11.5.2.1 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
  - 11.5.2.2 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
  - 11.5.2.3 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
  - 11.5.2.4 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
- 11.5.3 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
  - 11.5.3.1 Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.3.1.1 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.5.3.1.2 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.5.3.1.3 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.5.3.1.4 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.5.3.2 Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.3.2.1 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.5.3.2.2 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.5.3.2.3 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.5.3.2.4 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  - 11.5.3.3 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 11.5.3.3.1 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
    - 11.5.3.3.2 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
    - 11.5.3.3.3 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
    - 11.5.3.3.4 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration

13. Industry Landscape

13.1 Overview
13.2 Expansion
13.3 New Product Development
13.4 Merger and Acquisition
13.5 Partnerships
13.6 Other Business Strategies

14. Company Profiles

14.1 Boehringer Ingelheim International GmbH
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Lonza Group AG
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Samsung Biologics Co Ltd
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Merck KGaA
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 AbbVie Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 WuXi Biologics Inc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Ajinomoto Co Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Cytiva
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 AGC Biologics AS
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

Product Code: TIPRE00005512

List Of Tables

Table 1. Biopharmaceutical Contract Manufacturing Market Segmentation
Table 2. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 3. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 4. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 5. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 6. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 7. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 8. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 9. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 10. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 11. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 12. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 13. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 14. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 15. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 16. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 17. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 18. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 19. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 20. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 21. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 22. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 23. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 24. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 25. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 26. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 27. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 28. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 29. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 30. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 31. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 32. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 33. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 34. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 35. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 36. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 37. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 38. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 39. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 40. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 41. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 42. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 43. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 44. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 45. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 46. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 47. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 48. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 49. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 50. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 51. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 52. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 53. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 54. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 55. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 56. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 57. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 58. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 59. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 60. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 61. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 62. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 63. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 64. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 65. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 66. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 67. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 68. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 69. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 70. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 71. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 72. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 73. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 74. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 75. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 76. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 77. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 78. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 79. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 80. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 81. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 82. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 83. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 84. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 85. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 86. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 87. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 88. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 89. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 90. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 91. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 92. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 93. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 94. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 95. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 96. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 97. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 98. China: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 99. China: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 100. China: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 101. China: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 102. China: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 103. China: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 104. China: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 105. China: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 106. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 107. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 108. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 109. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 110. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 111. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 112. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 113. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 114. India: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 115. India: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 116. India: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 117. India: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 118. India: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 119. India: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 120. India: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 121. India: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 122. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 123. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 124. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 125. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 126. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 127. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 128. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 129. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 130. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 131. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 132. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 133. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 134. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 135. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 136. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 137. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 138. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 139. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 140. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 141. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 142. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 143. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 144. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 145. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 146. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 147. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 148. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 149. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 150. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 151. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 152. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 153. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 154. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 155. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 156. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 157. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 158. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 159. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 160. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 161. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 162. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 163. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 164. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 165. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 166. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 167. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 168. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 169. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 170. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 171. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 172. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 173. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 174. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 175. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 176. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 177. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 178. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 179. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 180. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 181. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 182. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 183. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 184. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 185. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 186. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 187. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 188. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 189. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 190. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 191. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 192. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 193. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 194. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 195. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 196. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 197. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 198. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 199. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 200. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 201. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 202. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 203. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 204. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 205. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 206. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 207. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 208. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 209. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 210. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
Table 211. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
Table 212. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
Table 213. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
Table 214. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 215. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 216. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
Table 217. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
Table 218. Heat Map Analysis by Key Players
Table 219. Glossary of Terms, Biopharmaceutical Contract Manufacturing Market

List Of Figures

Figure 1. Biopharmaceutical Contract Manufacturing Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Biopharmaceutical Contract Manufacturing Market Revenue (US$ Million), 2021-2031
Figure 5. Biopharmaceutical Contract Manufacturing Market Revenue (US$ Million), 2021-2031
Figure 6. Biopharmaceutical Contract Manufacturing Market Share (%) - by Product Type (2024 and 2031)
Figure 7. Biologics: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Biosimilar: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Biopharmaceutical Contract Manufacturing Market Share (%) - by Source (2024 and 2031)
Figure 10. Microbial: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Mammalian: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Biopharmaceutical Contract Manufacturing Market Share (%) - by Application (2024 and 2031)
Figure 13. Commercial: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Clinical: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Biopharmaceutical Contract Manufacturing Market Share (%) - by Therapeutic Area (2024 and 2031)
Figure 16. Oncology: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Autoimmune Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Respiratory Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Metabolic Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Neurology: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Infectious Diseases: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Others: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
Figure 24. North America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 25. United States: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 26. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 27. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 28. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
Figure 29. Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 30. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 31. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 32. France: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 33. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 34. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 35. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 36. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
Figure 37. Asia Pacific: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 38. China: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 39. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 40. India: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 41. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 42. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 43. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 44. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
Figure 45. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 46. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 47. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 48. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 49. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 50. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
Figure 51. South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 52. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 53. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 54. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 55. Company Positioning & Concentration

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ